2024-03-29 | TUTESTCD | Paired | CVLIND | Cardiovascular Lesion Indicator | C161485 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | DRCRLTLC | Disease Recurrence Relative Location | C123633 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | FIBLIND | Fibrotic Lesion Indicator | C161484 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | GRLIDENT | Graft Lesion Identification | C119567 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | HPTMIND | Hepatomegaly Indicator | C202449 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | LESIDENT | Lesion Identification | C94189 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | LMLIDENT | Limb Lesion Identification | C119568 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | MEASIND | Measurable Tumor Indicator | C161482 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | METIND | Metastatic Tumor Site Indicator | C154853 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | NTIND | Non-Target Indicator | C161483 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | PTSIND | Primary Tumor Site Indicator | C172602 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | SPLMIND | Splenomegaly Indicator | C202450 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TIND | Target Indicator | C178053 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TUBNIND | Bone Tumors Indicator | C186217 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TUEXMIND | Extramedullary Disease Indicator | C186218 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TUMERGE | Tumor Merged | C94525 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TUMIDENT | Tumor Identification | C94523 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | TUSPLIT | Tumor Split | C96642 | C96784 | C96783 | TUTEST |
2024-03-29 | TUTESTCD | Paired | VSLIDENT | Vessel Lesion Identification | C119569 | C96784 | C96783 | TUTEST |